Co-Marketing Agreement for Pfizer

Co-marketing agreements can limit Pfizer’s global presence, because it results in reduced revenue and payments to Pfizer's for their drugs. They have to share revenue with other parties. … "Co-Marketing Agreement for Pfizer" has a significant impact, so an analyst should put more weight into it. "Co-Marketing Agreement for Pfizer" will have a long-term negative impact on this entity, which subtracts from the entity's value. This statements will have a short-term negative impact on this entity, which subtracts from its value. This qualitative factor will lead to an increase in costs. This statement will lead to a decrease in profits.